Amendment No. 1 to Exclusive License Agreement between Seattle Children’s Hospital and Juno Therapeutics, Inc.

Contract Categories: Intellectual Property › License Agreements
Summary

Seattle Children’s Hospital (doing business as Seattle Children’s Research Institute) and Juno Therapeutics, Inc. have amended their original Exclusive License Agreement dated February 13, 2014. This amendment, effective August 4, 2014, adds new patent applications to the list of licensed patents under the agreement. All other terms of the original agreement remain unchanged and in effect. The amendment is signed by authorized representatives of both parties.

Read More Arrow
EX-10.12(B) 12 d772541dex1012b.htm AMENDMENT NO. 1 TO EXCLUSIVE LICENSE AGREEMENT Amendment No. 1 to Exclusive License Agreement

Exhibit 10.12B

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

Amendment No. 1

to the

Exclusive License Agreement

This Amendment No. 1, dated as of August 4, 2014, is entered into between Seattle Children’s Hospital d/b/a Seattle Children’s Research Institute, a Washington non-profit corporation (“Licensor”) and Juno Therapeutics, Inc., a Delaware corporation (“Licensee”)

 

  •   Licensor and Licensee previously entered into an Exclusive License Agreement, dated as of February 13, 2014 (“Original Agreement”).

 

  •   Licensor and Licensee want to amend the Original Agreement to add patent application(s) to the Licensed Patents, all as set forth below.

Accordingly, the parties agree as follows:

1. Exhibit A. Exhibit A is hereby amended to add the following patent application(s):

 

[***]    [***]    [***]
[***]    [***]    [***]
[***]    [***]    [***]

2. Exhibit A Restated. Exhibit A, in full, now reads as follows:

 

[***]    [***]    [***]
[***]    [***]    [***]
[***]    [***]    [***]
[***]    [***]    [***]
[***]    [***]    [***]
[***]    [***]    [***]

3. Full Force and Effect. Except as modified by this Amendment No. 1, all other terms of the Original Agreement will remain in full force and effect.

Seattle Children’s Hospital d/b/a Seattle Children’s Research Institute and Juno Therapeutics, Inc., Exclusive License Agreement, Amendment 1, Page 2 of 2

 

 

 

 

JUNO THERAPEUTICS, INC.    

SEATTLE CHILDREN’S HOSPITAL

D/B/A SEATTLE CHILDREN’S

RESEARCH INSTITUTE

By:  

/s/ H. Bishop

     By:  

/s/ James B. Hendricks, PhD

Name:  

H. Bishop

     Name:  

James B. Hendricks, PhD

Title:  

C.E.O.

     Title:  

President, Seattle Children’s Research Institute

 

2